trending Market Intelligence /marketintelligence/en/news-insights/trending/vqbwxauzidldh0srbwdmoa2 content esgSubNav
In This List

Compugen appoints chief medical officer

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Compugen appoints chief medical officer

Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.

Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.

Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.